Sandoz cuts outlook after Q3 sales miss
Sandoz shares are seen down after the company reported a Q3 sales miss and cut its outlook.
Story updates
08:13:38 AM UTC
SquawkNews
BRUSSELS (dpa-AFX) - Sandoz Group AG (SDZ.SW), a provider of generic medicines and biosimilars, Wednesday reported 4% growth in third-quarter sales. The company lowered its full-year 2026 sales growth outlook due to temporary market challenges and supply constraints in its biosimilars business, whi…